This respected International journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology. Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the editors welcome suggestions from potential authors. They should first write a brief outline of an intended review and send this to Dr Trevor Baglin or to Dr Jacob M Rowe.
这本受人尊敬的国际期刊《血液评论》是一个重要的信息资源，汇集了公认专家对临床实践和研究的评价。由领先的研究人员和从业者特别委托撰写的文章保证了真正的全球覆盖血液学的所有子专业。Blood Reviews发表涵盖临床和实验室血液学实践和研究的综述文章。虽然大多数评论都是邀请来的，但编辑们欢迎潜在作者的建议。他们应该首先写一个简短的大纲，打算审查，并发送给特雷弗巴格林博士或雅各布M罗博士。
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100648
Genotype-phenotype associations in Fanconi anemia: A literature review.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100589
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.09.001
Cellular therapy for acute myeloid Leukemia - Current status and future prospects.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.002
CAR-T - and a side order of IgG, to go? - Immunoglobulin replacement in patients receiving CAR-T cell therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100596
The emerging role of exosomes in multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/J.BLRE.2019.100595
Challenges of blood transfusions in β-thalassemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100588
The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.11.003
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
来源期刊：Blood reviewsDOI：10.1016/J.BLRE.2019.04.001
New developments in diagnosis, risk assessment and management in systemic amyloidosis.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100636
Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.005
Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.10.003
Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.07.001
Hypertension in hematologic malignancies and hematopoietic cell transplantation: An emerging issue with the introduction of novel treatments.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.003
Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100592
Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.003
Allogeneic hematopoietic cell transplantation; the current renaissance.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.11.001
Current and evolving understanding of atypical chronic myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.07.004
Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100594
Venous thromboembolism incidence in hematologic malignancies.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.06.002
Extramedullary disease in multiple myeloma - controversies and future directions.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.002
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100640
Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.003
Review of current transfusion therapy and blood banking practices.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100593
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100635
The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100639
Cellular immunotherapy for acute myeloid leukemia: How specific should it be?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.02.001
Why do myeloma patients have bone disease? A historical perspective.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100646
Modelling human haemoglobin switching.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2018.06.001
From multi-target anticoagulants to DOACs, and intrinsic coagulation factor inhibitors.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100615
Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100637
The central role of thrombin in bleeding disorders.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.006
Use of novel therapies in the treatment of light chain amyloidosis.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.05.005
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.01.001
Recent landmark studies in follicular lymphoma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.03.006
Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100641
Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100618
Blood doping: Then and now. A narrative review of the history, science and efficacy of blood doping in elite sport.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100632
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100643
The gut microbiota in transplant patients.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100614
Management of bleeding and procedures in patients on antiplatelet therapy.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100619
Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: A systematic review.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100633
Radiosynovectomy in haemophilia.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.01.002
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.04.004
Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100645
Too much iron: A masked foe for leukemias.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100617
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.06.001
Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100649
Thrombocytopenia in pregnancy: Diagnosis and approach to management.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100638
The emerging role of red blood cells in cytokine signalling and modulating immune cells.
来源期刊：Blood reviewsDOI：10.1016/j.blre.2019.100644
